Avopef (etoposide)
New dosage form
- Region
- 🇺🇸 US
- Active substance
- etoposide
- Company
- Avyxa Holdings
- Status
- Approved
- FDA approval
- Fri 13 Feb 2026
- Designations
- New dosage form
- Application
- NDA220200
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Fri 13 Feb 2026🇺🇸 FDA approval
FDA approves Avopef (etoposide): new dosage form
Avyxa Holdings; NDA220200; New dosage form; solution · source
Follow Avopef
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.